Legal and Regulatory Framework
Ireland operates under English Common Law, ensuring judicial predictability and strong contract enforcement—critical for international investors.
Key Legislations & Authorities
| Legislation/Authority | Function | Relevance |
| Companies Act 2014 | Consolidated company law framework | Modernized, simplified compliance |
| Taxes Consolidation Act 1997 | Primary tax legislation | Updated regularly for BEPS compliance |
| Companies Registration Office (CRO) | Company registry | 2-5 day incorporation timeline |
| Revenue Commissioners | Tax authority | Advance ruling system available |
| Central Bank of Ireland | Financial regulation | For regulated entities only |
| Irish Data Protection Commission | GDPR enforcement | Strictest in EU—critical for tech firms |
Practitioner Insight: Ireland’s advance tax ruling system allows certainty on complex structures before implementation—request rulings for transfer pricing, residence status, and treaty benefits.
Business Entity Selection – Strategic Analysis
Comparative Entity Framework
| Entity | Tax Treatment | Compliance Burden | Optimal Use Case |
| Private Company Limited by Shares (LTD) | 12.5% trading income; participation exemption available | Low—audit exemption possible | 90% of cases: operating companies, trading entities |
| Designated Activity Company (DAC) | Same as LTD | Higher—constitutional restrictions | Regulated activities (funds, insurance, aircraft leasing) |
| Irish Collective Asset-management Vehicle (ICAV) | Tax transparent/exempt | High—regulated | Investment funds, alternative investments |
| Unlimited Company (ULC) | Tax transparent for US purposes | Moderate | US tax planning: check-the-box eligible |
| Limited Partnership (LP) | Tax transparent | Low | Venture capital, private equity fund structures |
| Section 110 SPV | Tax-neutral | Moderate | Securitization, debt financing structures |
Critical Decision Matrix
Choose LTD if:
- Operating business generating trading income
- Need limited liability with minimal compliance
- Planning to use participation exemption or IP box
- Employees in Ireland (substance requirements)
Choose DAC if:
- Financial services, insurance, or fund management
- Regulated activity requiring CBI authorization
- Constitutional restrictions beneficial (creditor protection)
Choose ULC if:
- US parent company structure
- Need tax transparency for US federal purposes
- Avoiding Subpart F income issues
Choose Section 110 SPV if:
- Securitization or structured finance
- Irish Qualifying Investor Alternative Investment Fund (QIAIF)
- Debt capital markets transactions
Ireland’s Tax Ecosystem – The Complete Picture
Corporate Income Tax – Layered Analysis
| Income Type | Headline Rate | Effective Rate (with planning) | Key Exemptions/Reliefs |
| Trading Income | 12.5% | 10-12.5% | R&D credit, capital allowances |
| Passive/Investment Income | 25% | 0-12.5% | Participation exemption, KDB |
| Patent/IP Income | 12.5% | 6.25% | Knowledge Development Box (KDB) |
| Capital Gains | 33% | 0-12.5% | Substantial shareholding exemption, participation exemption |
Game-Changing Tax Features
A. Participation Exemption (Most Underutilized)
Conditions:
- Irish company holds ≥5% shareholding in foreign subsidiary
- Investee company is tax resident in EU/treaty country OR
- Investee company is resident in non-treaty jurisdiction BUT ≥75% of income is trading income
Benefits:
- Zero Irish tax on dividends received from qualifying subsidiaries
- Zero capital gains tax on disposal of qualifying shareholdings
- No minimum holding period (unlike many EU jurisdictions)
Practical Application:
Indian Parent Co
↓
Ireland HoldCo (LTD) ← Holds IP, collects royalties at 6.25%
↓
EU Operating Subs → Dividends flow tax-free to Ireland
Asia Operating Subs → Dividends (DTAA protection)
B. Knowledge Development Box (KDB) – 6.25% IP Tax
Eligible IP:
- Patents (pharma, tech, engineering)
- Computer programs (software, SaaS platforms)
- Certain copyrighted software
Requirements (OECD nexus compliant):
- R&D must be substantially conducted in Ireland
- Transfer pricing documentation mandatory
- Expenditure tracking for nexus calculation
Effective Rate Calculation:
Qualifying IP Income × (Qualifying Expenditure / Total Expenditure) × 50% = Income taxed at 6.25%
Remainder taxed at 12.5%
Practitioner Strategy: Locate actual R&D teams in Ireland (remote work models complicate nexus); maintain detailed cost tracking from day one.
C. R&D Tax Credit – 25% Above-the-Line
Mechanics:
- 25% tax credit on qualifying R&D expenditure
- Available as refundable credit over 3 years (critical for startups)
- Incremental spend not required (unlike many jurisdictions)
Qualifying Activities:
- Software development (including SaaS)
- Product prototyping and testing
- Process innovation
- Clinical trials (pharma/biotech)
Example:
R&D Spend: €1,000,000
Tax Credit: €250,000
Effective Cost: €750,000
After-tax cost (at 12.5%): €656,250 (34.4% effective subsidy)
Key Insight: Combine R&D credit with KDB for IP development → 25% upfront credit + 6.25% ongoing IP tax rate.
The Ireland-India Corridor – Advanced DTAA Strategies
DTAA Rates & Practical Implications
| Payment Type | India WHT (No Treaty) | DTAA Rate | Savings | Structuring Notes |
| Dividends | 20% | 10% (portfolio) / 15% (>25% holding) | 5-10% | Section 115-O abolished (2020)—double taxation risk managed |
| Interest | 20-40% | 10% | 10-30% | Thin capitalization rules apply |
| Royalties | 10% | 10% | Nil direct | Significant: India taxes gross; deduction benefits Irish recipient |
| Technical Fees | 10% | 10% | Nil direct | Includes software, management fees |
| Capital Gains (shares) | Per Income Tax Act | Residence-based | Structure-dependent | Substantial shareholding exemption in Ireland |
Critical Treaty Provisions Often Missed
1. Limitation on Benefits (LOB) – Article 28
Anti-abuse provisions:
- Irish company must have adequate substance
- ≥50% beneficial ownership by Irish/Indian residents OR
- Publicly traded on Irish/Indian exchange OR
- Active business test (≥50% income from active business)
Practical Compliance:
- Maintain physical office in Ireland (not just registered address)
- Local directors with actual decision-making authority
- Regular board meetings in Ireland (documented minutes)
- Bank accounts in Ireland with operational transactions
Tax Authority Scrutiny: Indian Revenue increasingly challenges treaty benefits without substance. Document:
- Employment contracts for Irish staff
- Lease agreements for Irish premises
- Evidence of strategic decisions made in Ireland
2. Principal Purpose Test (PPT) – MLI Integration
Ireland and India both signed the Multilateral Instrument (MLI). Key impact:
PPT Standard: Treaty benefit denied if “one of the principal purposes” is obtaining treaty benefit AND granting benefit would be contrary to treaty object/purpose.
Defensive Structuring:
- Demonstrate commercial rationale beyond tax (EU market access, IP protection, skilled workforce)
- Maintain proportionate substance to income flows
- Avoid “round-tripping” structures (Indian assets controlled via Ireland without genuine business)
3. Mutual Agreement Procedure (MAP) – Article 27
Underutilized benefit:
- Taxpayer can request MAP within 3 years of first notification of non-treaty-compliant action
- Competent authorities must endeavor to resolve disputes
- Arbitration clause available under MLI
When to invoke:
- Transfer pricing disputes (especially IP licensing)
- Residence determination conflicts
- Permanent establishment challenges
Company Formation – Practical Roadmap
Enhanced Requirements Table
| Requirement | Minimum Legal | Substance Best Practice | Cost Implication |
| Shareholders | 1 (any nationality) | Structure for treaty benefits | — |
| Directors | 1 (EEA resident) OR bond | 2+ locally resident with expertise | €25,000 bond (non-EEA) |
| Secretary | 1 (mandatory) | Professional service provider | €1,500-3,000/year |
| Registered Office | Irish address | Physical presence, not mailbox | €2,000-10,000/year |
| Share Capital | €1 | Adequate for intended activities | Variable |
| Employees | None (legal minimum) | 2-5 for substance (depends on revenue) | €40,000-200,000/year |
| Bank Account | Irish or EEA bank | Operational account with real transactions | Account fees vary |
Formation Timeline & Process
Phase 1: Pre-Incorporation (2-4 weeks)
- Name Reservation: Check availability via CRO (€20)
- Structure Design: Entity selection, shareholding structure
- Substance Planning: Office, directors, employees
- Banking Relationship: Pre-application (increasingly difficult—start early)
Phase 2: Incorporation (3-10 days)
- File Constitution (Form A1) with CRO
- Pay registration fee (€50 online / €100 paper)
- Receive Certificate of Incorporation
- Register for taxes (ROS system)
Phase 3: Post-Incorporation (2-4 weeks)
- Tax Registrations:
- Corporation Tax (CT)
- VAT (if applicable—mandatory if EU supplies)
- PAYE (if employees)
- RCT (if subcontractors)
- Statutory Registers: Maintain at registered office:
- Register of Members
- Register of Directors
- Register of Beneficial Owners (private, not public)
- Banking: Open corporate account (requires:
- Certificate of Incorporation
- Tax registration certificates
- Director ID verification
- Business plan
- Source of funds documentation
Banking Reality Check: Irish banks (AIB, Bank of Ireland) increasingly stringent. Alternative: Revolut Business, Wise, or EU banks (N26, Bunq) accept Irish companies but with limitations.
Transfer Pricing – Ireland’s Strict Regime
Ireland adopted OECD Transfer Pricing Guidelines and BEPS Actions 8-10 fully.
Documentation Requirements
| Revenue Threshold | Documentation | Deadline |
| ≥€250M (group) | Master File + Local File | Annual tax return filing |
| <€250M but related party transactions | Local File | Upon Revenue request (21 days) |
| Any threshold | CbC Reporting (if parent) | 12 months after year-end |
High-Risk Transactions (Automatic Scrutiny)
- IP Migration to Ireland
- Requires buy-in payment for transferred functions/risks
- Valuation report mandatory
- Exit taxation in source country likely
- Intra-group Royalties
- Must reflect DEMPE functions (Development, Enhancement, Maintenance, Protection, Exploitation)
- Substance requirements: R&D team, IP management staff
- Documentation: Intercompany agreements, functional analysis
- Management Fees/Cost Recharges
- 5% markup typically insufficient—Revenue seeks 8-15%
- Must demonstrate actual services rendered
- Time-tracking systems recommended
- Financing Arrangements
- Thin capitalization: 70:30 debt-to-equity safe harbor (not rule)
- Interest rates: EURIBOR + 2-4% (depends on credit profile)
- Interest limitation: 30% of EBITDA (per ATAD)
Advance Pricing Agreements (APAs)
Unilateral APAs: €20,000-50,000 fee; 18-24 months processing Bilateral APAs (with India): Recommended for IP structures; 24-36 months Small Cases: Revenue offers “Small Cases” fast-track for <€3M intercompany transactions
Substance Requirements – Post-BEPS Reality
Substance Framework by Business Model
| Business Model | Minimum Substance | Enhanced Substance (Audit-Proof) |
| Holding Company | 1 resident director; quarterly board meetings | 2 directors; Investment committee; Professional advisors |
| IP Holding/Licensing | 2-3 staff (IP management); Irish R&D activities | Full R&D team; DEMPE functions; Legal/commercial teams |
| Trading/Operating | Proportionate to revenue; real office | Full operations: sales, support, logistics |
| Treasury/Financing | Treasury specialist; Risk management | Treasury team; Documented policies; Real decision-making |
Red Flags (Revenue Audit Triggers)
❌ No employees but significant revenue/profits ❌ Registered address at service provider with no physical presence
❌ Directors resident outside Ireland with all meetings abroad
❌ Bank accounts outside Ireland with no Irish transactions
❌ Email domains not @company.ie
❌ IP owned but no R&D/DEMPE activities
❌ Profits disproportionate to functions/risks
Substance Budget (Annual)
Minimal Structure: €80,000-150,000
- 1 part-time executive + 1 administrative staff
- Serviced office space
- Professional services (accounting, legal, compliance)
Robust Structure: €250,000-500,000+
- 2-3 full-time staff (director-level + support)
- Dedicated office space
- Board meetings, legal, tax advisory, audit
IP/R&D Structure: €500,000-2,000,000+
- R&D team (5-15 staff depending on IP scope)
- Engineers, product managers, legal
- Lab/office space
- Ongoing R&D expenditure for KDB
VAT & Indirect Tax Considerations
VAT Registration Thresholds
| Activity | Threshold | Notes |
| Goods supply | €75,000 | Intra-EU B2B supplies often require registration regardless |
| Services supply | €40,000 | B2B services to EU: reverse charge (no Irish VAT) |
| Intra-EU acquisitions | €41,000 | Trigger for VAT registration |
Strategic VAT Structures
SaaS Companies (Critical)
Place of Supply Rules:
- B2B (business customers): Customer’s location (reverse charge—no Irish VAT)
- B2C (consumers):
- EU consumers: Ireland or customer country (depends on threshold: €10,000)
- Non-EU consumers: Outside scope of EU VAT
OSS (One-Stop Shop): Register in Ireland for all EU B2C sales—simplified returns.
Input VAT Recovery:
- Irish VAT on expenses (office, services): Fully recoverable if making taxable supplies
- Watch out: Non-deductible VAT on certain items (cars >50%, entertainment)
E-commerce/Dropshipping
IOSS (Import One-Stop Shop): For goods <€150 from non-EU suppliers. Distance Selling: €10,000 threshold for intra-EU sales before local registration required.
Annual Compliance Calendar – Actionable Timeline
Month-by-Month Obligations
| Period | Obligation | Form/Deadline | Penalty for Late Filing |
| Monthly | PAYE/PRSI (if employees) | 14th of following month | 10% + interest |
| Bi-Monthly | VAT Return | 19th or 23rd (ROS) | €4,000 |
| March 31 | Company Tax Return Deadline (if Form CT1 filed online + year-end 31 Dec) | Form CT1 | €500-1,500 + interest |
| June 30 | Financial Statements (if 31 Dec year-end) | CRO Form B1 + accounts | Late filing fees escalate |
| September | Preliminary Tax Payment | 90% of current/100% of prior year liability | Interest on underpayment |
| October 31 | Annual Return of Trading Details (Form 11, if required) | ROS | Penalties apply |
| November 1 | Corporation Tax Balance Due (if Dec 31 year-end) | — | Interest 8-10% p.a. |
Critical Compliance Notes
Corporation Tax:
- Preliminary tax: Due 6 months before year-end OR 1 month before year-end (if >90%)
- Return: 9 months after year-end (online filing)
- Payment: 9 months after year-end
Annual Return:
- Due 28 days before AGM OR 56 days after financial year-end (whichever later)
- Financial statements attached
Beneficial Ownership Register:
- Maintained at registered office (not filed publicly)
- Updated within 14 days of change
- Accessible by Revenue, Gardaí, legal orders
Ireland-India Structuring Playbooks
Scenario 1: Indian SaaS Company Expanding to Europe
Objective: Sell to EU customers, optimize tax, comply with GDPR.
Optimal Structure:
India Parent (OpCo) — R&D, support, back-office
↓ (License IP)
Ireland HoldCo/LicenseCo (LTD) — Owns IP, licenses to distributors
↓ (Distribute/Resell)
EU Customers — Direct sales or local distributors
Tax Flow:
- India develops software → Transfers IP to Ireland (buy-in payment—negotiate with Indian tax authority)
- Ireland entity:
- Collects royalties/license fees from EU distributors
- Income taxed at 6.25% (KDB) or 12.5% (if not KDB-eligible)
- Ireland pays India for ongoing R&D services (arm’s length—8-15% markup)
- Dividends from Ireland to India: 10% WHT (DTAA)
Substance in Ireland:
- 2-3 staff: Product manager, customer success, legal/compliance
- Office in Dublin/Cork (tech hubs)
- European sales/marketing handled from Ireland or local reps
Key Advantages:
- EU VAT compliance simplified (one registration)
- GDPR: Irish Data Protection Commissioner (experienced with tech firms)
- Transfer pricing alignment with actual functions
Scenario 2: Irish Holding Company for Indian Manufacturing Group
Objective: Expand manufacturing to Southeast Asia, Africa; centralize treasury.
Structure:
Indian Founders (Individuals)
↓ (Hold shares)
Ireland HoldCo (LTD) — Strategic headquarters, treasury
↓
India ManufacturingCo + Vietnam ManufacturingCo + Kenya ManufacturingCo
Tax Benefits:
- Participation Exemption: Dividends from India, Vietnam, Kenya → Ireland tax-free (if >5% stake + trading company test met)
- Capital Gains: Sale of subsidiary shares → Zero tax (substantial shareholding exemption)
- Treasury Centralization: Ireland HoldCo provides inter-company loans:
- Interest from subsidiaries: 10% WHT (India DTAA)
- Interest taxed in Ireland: 12.5%
- Net cost: 10% + 12.5% = 22.5% vs. higher local rates
Exit Planning:
- Private equity/strategic sale: Ireland HoldCo sells subsidiary shares
- No Irish CGT (participation exemption applies)
- No Indian CGT (treaty: taxable in residence state—Ireland)
- Founders’ capital gains: Personal tax planning (Irish non-dom regime, if relocated)
Compliance Keys:
- Substance: Treasury manager in Ireland (can be part-time initially)
- Board meetings: Quarterly in Ireland; document major decisions
- Funding: Adequate equity in Ireland HoldCo (avoid thin cap issues)
Scenario 3: Pharmaceutical IP Holding Structure
Objective: Develop patented drugs in India, commercialize globally via Ireland.
Structure:
India R&D Co — Clinical trials, drug development
↓ (Transfer patents)
Ireland IP HoldCo (LTD) — Patent ownership
↓ (License to)
Global Marketing Cos (US, EU, Asia) — Manufacture, distribute, sell
Tax Optimization:
- Patent Transfer: India to Ireland (negotiate advance ruling on exit tax)
- Royalty Income: Global licensees pay Ireland:
- 6.25% tax (KDB—patents qualify)
- DTAA benefits: Reduced WHT in licensee countries
- Ongoing R&D: Ireland pays India for continued R&D services
- Dividends: Ireland → India (or ultimate shareholders): 10-15% WHT
Substance Requirements (Critical for Pharma):
- Patent management team in Ireland
- Regulatory affairs expertise (EMA filings)
- Commercial team negotiating licenses
- Budget: €800,000-1,500,000/year minimum
Regulatory Note: If Ireland entity manufactures (unlikely), requires Health Products Regulatory Authority (HPRA) approval. Most structures: Ireland as IP owner/licensor only.
Pitfalls, Risks & Mitigation Strategies
Common Structuring Mistakes
| Mistake | Consequence | Mitigation |
| Inadequate substance | Treaty benefits denied; Irish Revenue challenges | Invest in genuine presence from Day 1 |
| No transfer pricing documentation | Adjustments + penalties (10-20%) | Prepare docs contemporaneously |
| Ignoring MLI/PPT | Treaty shopping allegations | Demonstrate commercial rationale |
| Over-leveraging (thin cap) | Interest deduction denied | Maintain 70:30 debt-equity ratio |
| No advance rulings | Uncertainty; audit risk | File for APA, tax rulings proactively |
| Director nominees without control | Substance failure | Use local directors with real authority |
| IP transfer without valuation | Exit tax + TP disputes | Engage valuation experts (Big 4) |
Audit Risk Management
Revenue Compliance Interventions:
- Aspect Query: Specific question (respond within 21 days)
- Risk Review: Desk-based audit (may escalate)
- Comprehensive Audit: Full investigation (provide all records)
Defensive Measures:
- File on time: Late filing = automatic scrutiny
- Professional advisors: Engage Irish-qualified accountants/lawyers
- Contemporaneous documentation: Transfer pricing, board minutes, substance evidence
- Voluntary disclosure: If errors found, disclose before audit (reduced penalties)
Post-Brexit Considerations
UK-Ireland Trade & Tax Implications:
Positives:
- Ireland = only English-speaking EU member post-Brexit
- Common Travel Area (CTA): Irish-UK mobility preserved (not for companies)
- Many UK companies relocating operations/HQ to Ireland
Challenges:
- Customs formalities: UK now third country for VAT/customs
- Tariffs: Eliminated under Trade & Cooperation Agreement (goods complying with rules of origin)
- Services: Financial services passporting lost (firms need Irish authorization)
Structuring Adaptation:
- UK companies: Set up Irish subsidiary for EU market access
- Dual structure: Ireland (EU) + UK (non-EU) entities for global coverage
Emerging Trends & 2025 Outlook
OECD Pillar Two – 15% Global Minimum Tax
Effective: Fiscal years starting after December 31, 2023 (Ireland implementing 2024-2025).
Impact on Ireland Structures:
- Large MNEs (€750M+ revenue): May face “top-up tax” if effective rate <15%
- Calculation: Complex—country-by-country, with substance-based carve-outs
- Ireland’s 12.5% rate: Still attractive (substance carve-out = 5% of payroll + 5% of tangible assets)
Strategy: Even with Pillar Two, Ireland remains competitive:
- Substance-based carve-out rewards genuine activity
- R&D credits, KDB still valuable (enhance substance, reduce top-up)
- Administrative ease, legal certainty vs. higher-rate complex jurisdictions
Digital Services & Remote Work
Permanent Establishment (PE) Risk:
- Employees working from home abroad → PE risk in that country
- Solution: Clear remote work policies; substance in Ireland primary
Digital Nomad Visa (proposed): Ireland considering visa for remote workers—watch space.
Practical Cost Structure (Realistic Budget)
Year 1: Formation + Setup
| Item | Cost (EUR) | Notes |
| Company Formation | 500-2,000 | DIY vs. agent |
| Legal Fees | 3,000-10,000 | Shareholder agreements, IP assignments |
| Tax Structuring Advisory | 10,000-50,000 | Critical for complex structures |
| Registered Office (Year 1) | 2,000-10,000 | Serviced office vs. dedicated |
| Accounting Setup | 2,000-5,000 | System implementation |
| Transfer Pricing Study | 15,000-50,000 | If intercompany transactions |
| Banking Application | 1,000-3,000 | Documentation, travel |
| Total Formation | 33,500-130,000 | Mid-range: ~€50,000 |
Year 1: Operational Costs
| Item | Cost (EUR) | Notes |
| Salaries (2 staff) | 80,000-200,000 | Director + admin/operational |
| Office Rent | 15,000-40,000 | Dublin vs. Cork/Galway |
| Accounting/Bookkeeping | 10,000-25,000 | Monthly + year-end |
| Tax Compliance | 5,000-15,000 | CT returns, VAT, PAYE |
| Audit (if required) | 5,000-15,000 | Depends on size |
| Legal/Advisory (retainer) | 10,000-30,000 | Ongoing compliance |
| Insurance | 3,000-10,000 | Directors, professional indemnity |
| IT/Software | 5,000-15,000 | Accounting, CRM, cybersecurity |
| Total Operational | 133,000-350,000 | Mid-range: ~€200,000 |
Total Year 1: €250,000-500,000 (includes substance, compliance, setup)
Ongoing (Years 2+): €150,000-300,000/year
Cost-Saving Tips:
- Remote-first: Hire outside Dublin (Cork, Galway 20-30% cheaper)
- Shared services: Use group accountants/HR in India for non-core functions
- Tech stack: Leverage automation (Xero, Stripe, Deel for payroll)
Action Plan – 90-Day Implementation Roadmap
Days 1-30: Planning & Design
- [ ] Define business model and revenue projections
- [ ] Select entity type (LTD vs. DAC vs. ULC)
- [ ] Design shareholding structure (direct vs. holding company)
- [ ] Identify substance requirements (office, directors, employees)
- [ ] Engage Irish tax advisor (Big 4 or specialized boutique)
- [ ] Draft intercompany agreements (IP license, services, loans)
- [ ] Initiate transfer pricing study (if applicable)
Days 31-60: Formation & Setup
- [ ] Reserve company name with CRO
- [ ] Incorporate company (Form A1)
- [ ] Appoint directors and secretary
- [ ] Allot shares and issue share certificates
- [ ] Register for taxes (Corporation Tax, VAT, PAYE)
- [ ] Open bank account (start application early—4-8 weeks)
- [ ] Secure office space (lease or serviced office)
- [ ] Set up accounting system (Xero, QuickBooks, or SAP)
- [ ] Draft employment contracts for Irish staff
- [ ] File for tax rulings (if complex structure—add 3-6 months)
Days 61-90: Operationalization
- [ ] First board meeting (document key decisions)
- [ ] Execute intercompany agreements
- [ ] Commence operations (invoice customers, pay suppliers)
- [ ] Implement transfer pricing policies
- [ ] Set up payroll (outsource to provider like Mazars, Grant Thornton)
- [ ] Register for statutory deductions (PAYE, USC, PRSI)
- [ ] File beneficial ownership information (private register)
- [ ] Establish compliance calendar and responsibilities
- [ ] Quarterly review: Substance, transactions, documentation
FAQs – Expert Answers
Q1: Can a 100% Indian-owned company claim Ireland-India DTAA benefits?
A: Yes, IF adequate substance in Ireland. Post-MLI, demonstrate:
- Commercial rationale (not just tax)
- Proportionate substance (staff, office, decision-making)
- Active business operations (not just passive IP holding)
Expect scrutiny—document thoroughly.
Q2: Is the Irish ULC still useful for US tax planning post-TCJA?
A: Yes, but diminished. Key uses:
- Check-the-box election: Transparent for US purposes (avoid Subpart F)
- Interest deductibility: US parent pays interest to Irish ULC (deductible in US)
- Caution: GILTI may still apply; BEAT considerations